4.4 Article

Continuous Glucose Monitoring Impact and Implications of Real-World Evidence: Past, Present, and Future

期刊

DIABETES TECHNOLOGY & THERAPEUTICS
卷 25, 期 -, 页码 S5-S13

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/dia.2023.0057

关键词

Continuous glucose monitoring; CGM; Type 1 diabetes; Type 2 diabetes; Real-world evidence; Prospective

向作者/读者索取更多资源

Randomized controlled trials show the benefits of continuous glucose monitoring (CGM) in intensive insulin regimens for diabetes patients. Other studies have investigated CGM's impact on nonintensive therapies, leading to changes in payer coverage and expanding use. This article reviews recent real-world studies, highlights key lessons, and discusses increasing access to CGM for all diabetes patients.
Randomized controlled trials, which are considered the highest level of scientific evidence, have shown significant glycemic benefits associated with use of continuous glucose monitoring (CGM) in individuals with diabetes who are treated with intensive insulin regimens. However, numerous prospective, retrospective, and observational studies have investigated the impact of CGM in various diabetes populations treated with nonintensive therapies. Results from these studies have contributed to changes in payer coverage, prescriber behaviors, and expanding use of CGM. This article reviews findings from recent real-world studies, highlights the key lessons learned from these studies, and discusses how we need to move forward in increasing utilization of and access to CGM among all diabetes patients who would benefit from this technology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据